The Division for Cardiovascular Pharmacology (CVP) serves members with
interests in all aspects of cardiovascular pharmacology research from
the molecular level to whole animal and clinical studies. Specific areas
include, but are not limited to, mechanisms of cardiovascular drug
action, autonomic pharmacology, cell signaling, cardiac pharmacology,
endothelial and smooth muscle cell pharmacology, hemostasis and
thrombosis, blood vessel wall interactions, and mechanisms involved in
the pathogenesis, diagnosis and treatment of cardiac, renal, pulmonary
and cerebral vascular disease, including hypertension, coronary artery
disease and stroke.